Michael Miller is a Group Director and Global Development Lead in Specialty Therapeutics at AbbVie, focusing on virology and infectious diseases. With extensive expertise in clinical study design, drug development, and medical affairs, they have overseen the creation and execution of clinical development plans for COVID-19 antivirals and contributed to cross-functional teams across various therapeutic areas. Previously, they held several leadership roles at AbbVie and Abbott Laboratories, managing programs in men's health and driving regulatory submissions. Michael earned a Pharm.D. from Duquesne University and completed a fellowship in clinical research and drug development at West Virginia University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices